Last reviewed · How we verify
NCT05530915
Guayusa: The Effect of an Herbal Extract on Alertness and Mental Fatigue
NA trial testing Gel capsule in Attention Difficulties in 60 participants. Completed in 7 November 2022.
7 November 2022
Quick facts
| Lead sponsor | PepsiCo Global R&D |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | basic science |
| Enrollment | 60 |
| Start date | 27 July 2022 |
| Primary completion | 7 November 2022 |
| Estimated completion | 7 November 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Gel capsule
Conditions studied
- Attention Difficulties — all drugs for Attention Difficulties →
Sponsor
PepsiCo Global R&D — full company profile →
Who can join
Adults 18 to 55, any sex, with Attention Difficulties. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this randomized, double-blind, placebo-controlled, cross-over study is to assess the acute effects of a novel ingredient, guayusa on alertness and mental fatigue compared to a placebo. This trial will utilize the COMPASS cognitive task and cognitive demand battery (CDB) and mood, motivation, and energy measures with assessments taking place at baseline, 60- and 120-minutes post treatment on three separate testing days separated by \~7 days.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05530915
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Attention Difficulties
Currently open trials in the same condition.
- NCT06114017 — Effect of a Week-long Social Media Abstention on Sustained Attention Functions · NA · recruiting
- NCT05528939 — Feasibility/Acceptability of Attentional-Control Training in Survivors · NA · recruiting
- NCT05802680 — Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation · NA · recruiting
Other PepsiCo Global R&D trials
Trials by the same sponsor.
- NCT07429201 — Comparing an Electrolyte-Carbohydrate Beverage to Water During Ramadan · NA · completed
- NCT07400614 — Evaluating the Impact of Energy Drink Formulas on Alertness for an Extended Period · NA · recruiting
- NCT07427654 — Determination of the Glycemic Index of Products Varying in Levels of Refined and Whole Grain Corn · NA · completed
- NCT07298863 — The Effect of Hydration Status on Substrate Oxidation at Rest and During Light and Moderate Exercise · NA · recruiting
- NCT07217834 — Effects of a Glycerol-Electrolyte Beverage on Fluid Balance in Healthy Euhydrated Men and Women · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05530915 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by PepsiCo Global R&D
- Last refreshed: 14 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05530915.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing